References
- Nebbioso M, Zicari AM, Lollobrigida V, Marenco M, Duse M. Assessment of corneal alterations by confocal microscopy in vernal keratoconjunctivitis. Semin Ophthalmol. 2015;30(1):40–43.
- Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem. 1973;38(1):14–19.
- Yu SS, Li HJ, Goodwin GH, Johns EW. Interaction of non-histone chromosomal proteins HMG1 and HMG2 with DNA. Eur J Biochem. 1977;78(2):497–502.
- Venereau E, Casalgrandi M, Schiraldi M, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 2012;209(9):1519–1528.
- Pucci N, Novembre E, Cianferoni A, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy, Asthma Immunol: off Pub Am Coll Allergy, Asthma, Immunol. 2002;89(3):298–303.
- Nebbioso M, Zicari AM, Celani C, Lollobrigida V, Grenga R, Duse M. Pathogenesis of vernal keratoconjunctivitis and associated factors. Semin Ophthalmol. 2015;30(5–6):340–344.
- De Smedt S, Wildner G, Kestelyn P. Vernal keratoconjunctivitis: an update. Br J Ophthalmol. 2013;97(1):9–14.
- Vichyanond P, Pacharn P, Pleyer U, Leonardi A. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatr Allergy Immunology: off Publication Eur Soc Pediatr Allergy Immunol. 2014;25(4):314–322.
- Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21(3):319–339.
- Leonardi A, Bogacka E, Fauquert JL, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy. 2012;67(11):1327–1337.
- Zicari AM, Nebbioso M, Zicari A, et al. Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report. Eur Rev Med Pharmacol Sci. 2013;17(9):1242–1244.
- Zicari AM, Zicari A, Nebbioso M, et al. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis. Pediatr Allergy Immunology: off Publication Eur Soc Pediatr Allergy Immunol. 2014;25(1):57–63.
- Pachydaki SI, Tari SR, Lee SE, et al. Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res. 2006;82(5):807–815.
- Arimura N, Ki IY, Hashiguchi T, Sakamoto T, Maruyama I. High-mobility group box 1 protein in endophthalmitis. Graefe’s Archive for Clin Exp Ophthalmol = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2008;246(7):1053–1058.
- Arimura N, Ki-I Y, Hashiguchi T, et al. Intraocular expression and release of high-mobility group box 1 protein in retinal detachment. Lab Invest. 2009;89(3):278–289.
- Cavone L, Muzzi M, Mencucci R, et al. 18beta-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis. Ocul Immunol Inflamm. 2011;19(3):180–185.
- Han SJ, Min HJ, Yoon SC, et al. HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation. Cell Death Dis. 2015;6:e1863.
- Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139–162.
- Musumeci D, Roviello GN, Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther. 2014;141(3):347–357.